Ocular Therapeutix Inc. buy Bank of America Co.
Start price
09.02.24
/
50%
€5.02
Target price
09.02.25
€13.91
Performance (%)
-10.90%
Price
29.04.24
€4.47
Summary
This prediction is currently active. The price of Ocular Therapeutix Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.90%. This prediction currently runs until 09.02.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -6.128% | -6.128% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat